Nitrovas 30mg Tablet SR
Marketer
Veritaz Healthcare Ltd
Salt Composition
Isosorbide Mononitrate (30mg)
Overview Nitrovas 30mg Tablet SR
Isosorbide mononitrate 30mg extended-release tablets are prescribed to proactively manage angina pectoris. Their mechanism involves vasodilation, improving blood flow to the heart. This medication is not for treating ongoing angina episodes. Isosorbide mononitrate 30mg extended-release tablets can be ingested with or without food. Dosage and frequency are determined by your physician and may be adjusted based on efficacy. Consistent use, as directed, is crucial, even during symptom-free periods, as it prevents future angina. Discontinuation, particularly abrupt cessation, significantly elevates angina risk. Lifestyle modifications—including balanced nutrition, regular exercise, and smoking cessation—enhance treatment effectiveness. Tolerance may develop over time, necessitating adherence to the prescribed regimen to maintain efficacy. Common adverse effects include headache, flushing, upper respiratory infections, abdominal discomfort, allergic reactions, chest pain, and diarrhea. Your doctor can advise on managing these side effects, which may involve analgesics, increased hydration, and alcohol avoidance. Prior to commencing treatment, inform your physician of any pre-existing conditions such as hypotension, glaucoma, renal impairment, or congestive heart failure. Disclosure of all other medications is essential due to potential interactions or contraindications. Concurrent use with erectile dysfunction medications is contraindicated. Pregnant or breastfeeding individuals should consult their physician regarding the suitability of this medication. Regular monitoring of blood pressure and heart rate may be implemented during treatment.
Uses of Nitrovas 30mg Tablet SR
Avoiding angina pectoris (chest pain from heart issues)
Major Benefits of Nitrovas 30mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. Nitrovas 30mg Sustained-Release Tablets may be ingested with or without food, although consistent timing is recommended.
Common Side effects of Nitrovas 30mg Tablet SR:
- Headache
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upper respiratory tract infection
- Abdominal pain
- Allergic reaction
- Chest pain
- Diarrhea
How to use Nitrovas 30mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nitrovas 30mg Sustained-Release Tablets can be consumed with or without food, though consistent timing is recommended.
How Nitrovas 30mg Tablet SR works:
Nitrovas 30mg Sustained-Release tablets contain nitrates, which widen both peripheral arteries and veins. This venous dilation leads to increased blood volume in the extremities, lowering the amount of blood returning to the heart. Consequently, the heart's workload is reduced, diminishing its oxygen and blood requirements.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nitrovas 30mg sustained-release tablets and alcohol can trigger adverse effects including facial redness, tachycardia, queasiness, polydipsia, angina, and hypotension (a Disulfiram-like reaction).
PregnancyCONSULT YOUR DOCTOR
Sustained-release Nitrovas 30mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Nitrovas 30mg sustained-release tablets and breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a Nitrovas 30mg sustained-release tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Nitrovas 30mg tablets are considered safe for patients with kidney disease; no dosage alteration is typically necessary. Nevertheless, consult your physician if you have pre-existing kidney impairment.
LiverSAFE IF PRESCRIBED
Patients with liver disease can likely use Nitrovas 30mg Tablet SR safely. Available evidence indicates dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Nitrovas 30mg Tablet SR :
Should you forget a Nitrovas 30mg Tablet SR dose, take it immediately if you remember. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nitrovas 30mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Nitrate compounds |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | No donations accepted. |
3,018 People bought this recently